Up-to-date experience with lenalidomide therapy in patients with multiple myeloma in the Czech Republic - pilot data in highly pretreated patients

Abstract

Due to its efficacy, lenalidomide has been among today´s three most widely used drugs for multiple myeloma. Our experience confirms its efficacy in highly pretreated patients with relapsed MM.

Keywords

• lenalidomide
• multiple myeloma
• therapeutic efficacy